1. 1. Bafghi AF, Pourmazar S, Shamsi F. Five-Year Status of Malaria (a Disease Causing Anemia) in Yazd, 2008-2012. Iranian journal of pediatric hematology and oncology. 2013;3(3):91.
2. Sillehu S, Rumaolat W, Cahyawati S, Utami TN, Kartika D, Rina W. Malaria Prevention and Eradication Program Towards Malaria-Elimination in West-Seram. Indian Journal of Forensic Medicine and Toxicology. 2020;14(2).
3. Yang Y, Liu Y, Xie Z, Wu S, Yang L, Li W, et al. Epidemiology of malaria in Yulin, South China 1999–2016: Imported Malaria threatens zero local case status. Vector-Borne and Zoonotic Diseases. 2018;18(10):533-8.
4. Cibulskis RE, Alonso P, Aponte J, Aregawi M, Barrette A, Bergeron L, et al. Malaria: global progress 2000–2015 and future challenges. Infectious diseases of poverty. 2016;5(1):1-8.
5. Thellier M, Simard F, Musset L, Cot M, Velut G, Kendjo E, et al. Changes in malaria epidemiology in France and worldwide, 2000–2015. Médecine et Maladies Infectieuses. 2020;50(2):99-112.
6. CS B, Lokossou V, Landier J, Sylla B, Tougri G, Ouedraogo B, et al. Geo-epidemiology of Malaria in Burkina Faso, 2013-2018: a recent re-increase. 2021.
7. Organization WH. World malaria report 2020: 20 years of global progress and challenges. 2020.
8. Vatandoost H, Raeisi A, Saghafipour A, Nikpour F, Nejati J. Malaria situation in Iran: 2002–2017. Malaria journal. 2019;18(1):1-7.
9. Nejati J, Tabatabaei SM, Salehi M, Saghafipour A, Mozafari E. Some probable factors affecting the malaria situation before and at the beginning of a pre-elimination program in southeastern Iran. Journal of Parasitic Diseases. 2017;41(2):503-9.
10. Azizi H, Davtalab-Esmaeili E, Farahbakhsh M, Zeinolabedini M, Mirzaei Y, Mirzapour M. Malaria situation in a clear area of Iran: an approach for the better understanding of the health service providers’ readiness and challenges for malaria elimination in clear areas. Malaria journal. 2020;19(1):1-10.
11. Hassanpour G, Mohebali M, Zeraati H, Raeisi A, Keshavarz H. Asymptomatic malaria and its challenges in the malaria elimination program in Iran: a systematic review. Journal of arthropod-borne diseases. 2017;11(2):172.
12. Bruneel F. Human cerebral malaria: 2019 mini review. Revue neurologique. 2019;175(7-8):445-50.
13. Khalili MB, Anvari-Tafti M, Sadeh M. Epidemiological pattern of malarial disease in the province of Yazd, Iran (Since 1986-2006). World J Med Sci. 2009;4(1):41-5.
14. Rathore D, McCutchan TF, Sullivan M, Kumar S. Antimalarial drugs: current status and new developments. Expert Opinion on Investigational Drugs. 2005;14(7):871-83.
15. EDRISIAN GH. Malaria in Iran: Past and present situation. 2006.
16. Khan H, Khattak AM. A study of prevalence of malaria in adult population of DI Khan, Pakistan. Biomedica. 2006;22(14):99-104.
17. Sheikh AS, Sheikh AA, Sheikh NS, Paracha SM. Endemicity of malaria in Quetta. Pak J Med Res. 2005;44(1):41-50.
18. Yang D, Xu C, Wang J, Zhao Y. Spatiotemporal epidemic characteristics and risk factor analysis of malaria in Yunnan Province, China. BMC public health. 2017;17(1):1-10.
2. Bafghi AF, Pourmazar S, Shamsi F. Five-Year Status of Malaria (a Disease Causing Anemia) in Yazd, 2008-2012. Iran J Pediatr Hematol Oncol. 2013;3(3):91.
3. Sillehu S, Rumaolat W, Cahyawati S, Utami TN, Kartika D, Rina W. Malaria Prevention and Eradication Program Towards Malaria-Elimination in West-Seram. Indian J Forensic Med Toxicol. 2020;14(2).
4. Epidemiology of Malaria in Yulin, South China 1999–2016: Imported Malaria Threatens Zero Local Case Status
5. Malaria: Global progress 2000 – 2015 and future challenges